GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants

Nicole S. Delino, Manabu Aoki, Hironori Hayashi, Shin-ichiro Hattori, Simon B. Chang, Yuki Takamatsu, Cuthbert D. Martyr, Debananda Das, Arun K. Ghosh, Hiroaki Mitsuya
  • Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals
  • DOI: 10.1128/aac.02060-17

The authors haven't yet claimed this publication.

Read Publication

In partnership with: